Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zoetis    ZTS

ZOETIS

(ZTS)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/12/2019 08/13/2019 08/14/2019 08/15/2019 08/16/2019 Date
123.96(c) 124.7(c) 121.79(c) 123.68(c) 125.37(c) Last
1 423 358 1 787 789 1 875 196 1 650 691 1 199 094 Volume
-0.89% +0.60% -2.33% +1.55% +1.37% Change
More quotes
Financials (USD)
Sales 2019 6 231 M
EBIT 2019 2 310 M
Net income 2019 1 422 M
Debt 2019 3 956 M
Yield 2019 0,48%
Sales 2020 6 660 M
EBIT 2020 2 544 M
Net income 2020 1 707 M
Debt 2020 3 187 M
Yield 2020 0,55%
P/E ratio 2019 42,5x
P/E ratio 2020 34,4x
EV / Sales2019 10,2x
EV / Sales2020 9,47x
Capitalization 59 871 M
More Financials
Company
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - livestock (54.1%): cattle (55.6% of sales), swine (21%), poultry (16.5%), fish (4.2%) and other (2.7%); - pets (44.9%): cats and dogs (93.6% of net sales) and... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Zoetis
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOETIS
08/15ZOETIS : Adds Stablelab® Hand-held Diagnostic Test to its Equine Portfolio
PU
08/15ZOETIS : to Participate in the Morgan Stanley 17th Annual Global Healthcare Conf..
BU
08/14ZOETIS : Completes Acquisition of Platinum Performance, a Leading Nutrition-Focu..
BU
08/06ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/06Zoetis on Pace for Record High After 2Q Earnings Beat -- Data Talk
DJ
08/06ZOETIS : Shares Rise Amid Earnings Beat, Guidance Raise
DJ
08/06GLOBAL MARKETS LIVE : Amazon, Tencent, New Media, Pernod…
08/06ZOETIS : 2Q Earnings Snapshot
AQ
08/06ZOETIS INC. : Results of Operations and Financial Condition (form 8-K)
AQ
08/06ZOETIS : Announces Second Quarter 2019 Results
PU
More news
Analyst Recommendations on ZOETIS
More recommendations
Sector news : Veterinary Drugs
08/16ABBVIE : Gets FDA OK for Rheumatoid Arthritis Drug Rinvoq
DJ
08/16CELGENE : FDA Grants Approval to Celgene's Impact for Bone Marrow Disorder Treat..
DJ
08/16ALLERGAN : Form 8.3 - Allergan Plc
DJ
08/16NOVO NORDISK : contests Danish lawsuit claiming $1.75 billion
RE
08/16Correction to AstraZeneca's Lynparza Clinical Trial Article on Wednesday
DJ
More sector news : Veterinary Drugs
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 126,13  $
Last Close Price 125,37  $
Spread / Highest target 11,7%
Spread / Average Target 0,60%
Spread / Lowest Target -32,2%
EPS Revisions
Managers
NameTitle
Juan Ramón Alaix Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn C. David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS46.56%59 064
ELANCO ANIMAL HEALTH INC-6.88%10 888
DECHRA PHARMACEUTICALS39.81%3 591
JINYU BIO-TECHNOLOGY CO LTD49.34%2 581
VIRBAC43.94%1 515
PHIBRO ANIMAL HEALTH CORP-2.95%1 215